SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Celgene Corporation

254

Celgene

CELG

Looking for leads, investment insights, or competitive intelligence?

CEO

Mark J. Alles

CEO Title

Chief Executive Officer & Director

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Summit, NJ

Years on Fortune 500 List

6

Employees

7,132

Profile provided by S&P Global.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$11,22921.3%
Profits ($M)$1,999.224.8%
Assets ($M)$28,086
Total Stockholder Equity ($M)$6,599.3
Market Value — as of March 31, 2017 ($M)$96,802
Profit Ratios
Profit as % of Revenues17.8%
Profits as % of Assets7.1%
Profits as % of Stockholder Equity30.3%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)2.49
EPS % Change (from 2015)28.4%
EPS % Change (5 year annual rate)11.8%
EPS % Change (10 year annual rate)39.4%
Total Return
Total Return to Investors (2016)-3.3%
Total Return to Investors (5 year, annualized)27.9%
Total Return to Investors (10 year, annualized)14.9%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a